70 results on '"Salman-Monte, T."'
Search Results
2. AB1124 PRELIMINARY ANALYSIS OF THE RATIOS BETWEEN ADVANCED-GLYCATION END PRODUCTS (AGEs) AND THEIR SOLUBLE RECEPTOR (sRAGE) AS BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS
3. POS1135 ADVANCEMENTS IN DIAGNOSING STIFFNESS AND VASCULARIZATION OF SYNOVITIS IN HANDS AND WRISTS USING SHEAR WAVE ELASTOGRAPHY AND COLOR-DOPPLER ULTRASOUND IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
4. AB1354 SPANISH NATIONAL MULTICENTER REGISTRY OF PREGNANCY IN SYSTEMIC AUTOINMUNE RHEUMATIC DISEASES
5. AB1654-PARE DOES THE PERSPECTIVE OF SLE PATIENTS MATCH THE EXPERT OPINION AND DEFINITIONS OF REMISSION AND LOW DISEASE ACTIVITY STATE? PROSPECTIVE ANALYSIS OF 500 PATIENTS FROM A SPANISH MULTICENTER COHORT
6. AB1008 BRIDGING THE GAP BETWEEN PATIENT’S PERCEPTION ON QUALITY OF LIFE AND DISEASE ACTIVITY AND DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS
7. AB1653-PARE LACK OF AWARENESS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS CONSEQUENCES ON A COHORT OF MODERATE AND SEVERE PATIENTS IN SPAIN: THE LUPUSVOICE STUDY
8. AB1134 SERUM ADVANCED GLYCATION END-PRODUCTS AND THEIR SOLUBLE RECEPTOR AS POTENTIAL NEW BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS
9. Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?
10. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review
11. Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review
12. POS1144 EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT
13. AB0822 SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS. COMBINATION
14. POS0079-HPR PATIENT-REPORTED OUTCOMES MEASURES FOR SYSTEMIC LUPUS ERYTHEMATOSUS: AN EXPERT DELPHI CONSENSUS TO GUIDE IMPLEMENTATION IN ROUTINE CARE
15. AB1685 ANTI-DFS70: ARE THEY HELPFUL WHEN ASSESSING FOR SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES?
16. AB1677 VALIDATION ANALYSIS OF THE PHYSICIAN GLOBAL ASSESSMENT (PGA) SCALE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS INCLUDED IN RELESSER-PROS REGISTRY
17. AB0594 CLINICAL SIGNIFICANCE OF ANTI-LA ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS
18. AB0585 COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)
19. AB1460 ACCUMULATED ADVANCED GLYCATION ENDPRODUCTS ARE SIGNIFICANTLY HIGHER IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES THAN IN HEALTHY POPULATION.
20. AB0486 INFLAMMATORY MUSCULOSKELETAL ABNORMALITIES BY CONTRAST ENHANCED MRI IN SLE PATIENTS
21. POS0759 DOES LLDAS DEFINITION MATCH THE RHEUMATOLOGIST OPINION? THE FIRST VISIT EVALUATION OF A LONGITUDINAL SPANISH MULTICENTER STUDY TO ASSESS REASONS OF DISAGREEMENT.
22. AB0490 INFLAMMATORY MUSCULOSKELETAL ABNORMALITIES BY CONTRAST ENHANCED MRI SHOW A SPECIFIC PROFILE IN SLE PATIENTS
23. AB0491 MUSCULOSKELETAL INVOLVEMENT, CONFIRMED BY CONTRAST ENHANCED MRI, CONTRIBUTES TO A WORSE HEALTH-RELATED QUALITY OF LIFE IN SLE PATIENTS
24. AB0344 PREVALENCE AND RISK FACTORS FOR SEROSITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE CONTROL STUDY
25. OP0292 SURVEY ON THE PERCEPTIONS AND EXPERIENCES OF SPANISH LUPUS PATIENTS. RESULTS ABOUT KNOWLEDGE OF THE DISEASE AND RELATIONSHIP TO DISEASE-FELUPUS SURVEY
26. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)
27. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review
28. Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review
29. AB0560 DESCRIPTIVE ANALYSIS AND STUDY OF CORRELATIONS IN A COHORT OF PATIENTS WITH INFLAMMATORY MYOPATHIES
30. FRI0111 TOCILIZUMAB MAY INDUCE SECONDARY HYPOGAMMAGLOBULINAEMIA. A RETROSPECTIVE CASE SERIES OF 42 PATIENTS
31. FRI0162 COMPARISON OF MUSCULOSKELETAL INVOLVEMENT OF WRIST AND HAND BY MRI IN TWO SYSTEMIC LUPUS ERYTHEMATOSUS GROUPS: HAND ARTHRITIS AND HAND ARTHRALGIA
32. Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
33. ANTI-DFS70: ARE THEY HELPFUL WHEN ASSESSING FOR SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES?
34. PREVALENCE AND RISK FACTORS ASSOCIATED WITH THROMBOCYTOPENIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AT HOSPITAL DEL MAR.
35. CONCENTRATIONS OF SERUM ADVANCED GLYCATION END PRODUCTS (AGES) CARBOXYETHYLLYSINE CORRELATE WITH INDICES OF ACTIVITY AND SPECIFIC MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS.
36. BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT.
37. EVALUATION OF SATISFACTION AND EFFICACY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN DAILY CLINICAL PRACTICE.
38. EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT.
39. AB0381 Change is good, but what is better? retrospective study in clinical practice first switch with different biological therapies in rheumatoid arthritis
40. FRI0184 The profiles of patients with rheumatoid arthritis according to their beliefs in their biological drugs. arco study
41. THU0273 Prevalence and factors associated with fatigue in female SLE patients at the hospital del mar / parc de salut mar
42. Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients
43. SYSTEMIC SCLEROSIS ASSOCIATED ANTIBODIES POSITIVITY IN SYSTEMIC SCLEROSIS PATIENTS: SINGLE VS. COMBINATION.
44. FRI0564 RA and Remission: Acceptable Inflammatory Activity in Magnetic Resonance Imaging Associated with Absence of Progression of Erosions at One Year
45. FRI0582 Could MRI of the Hand Improve the Accuracy of the 2010 ACR/EULAR Criteria for Rheumatoid Arthritis?
46. Differences between clinical and laboratory findings in patients with recent diagnosis of SLE according to the positivity of anti-dsDNA by the Crithidia luciliae method
47. Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients.
48. THU0032 Fibromyalgia Prevalence and Related Factors in A Large Spanish Cohort of Patients with Systemic Lupus Erythematosus: Table 1.
49. PReS-FINAL-2309: Juvenile systemic lupus erythematosus: a case series depiction in an urban community and a comparison to an adult case series
50. AB0196 Do patients with early ra and vitamin d deficiency have increased disease activity at the time of diagnosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.